ERAS · Erasca, Inc.

$18.38 +0.52 (+2.91%) At close · Aug 14

Market Cap

$6.43B

349.76M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Lim	Chairman, Chief Executive Officer, and Co-Founder	$670,400	—	—	$3,135,250	$482,688	$10,500	$4,298,838
David Chacko	Chief Financial Officer and Chief Business Officer	$516,700	—	—	$1,003,280	$248,016	$10,500	$1,778,496
Shannon Morris	M.D., Ph.D. Chief Medical Officer	$515,000	—	—	$978,198	$247,200	$10,500	$1,750,898

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Lim	Chairman, Chief Executive Officer, and Co-Founder	$644,600	—	—	$2,794,308	$444,774	$10,350	$3,894,032
David Chacko	Chief Financial Officer and Chief Business Officer	$492,100	—	—	$1,155,690	$226,366	$10,350	$1,884,506
Shannon Morris	M.D., Ph.D. Chief Medical Officer	$486,500	—	—	$866,870	$223,790	$10,350	$1,587,510

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Lim	Chairman, Chief Executive Officer, and Co-Founder	$622,800	—	—	$4,419,750	$354,996	$9,900	$5,407,446
David Chacko	Chief Financial Officer and Chief Business Officer	$475,500	—	—	$1,767,900	$180,690	$9,900	$2,433,990
Ebun S. Garner	General Counsel and Corporate Secretary	$433,000	—	—	$1,414,320	$164,540	$9,900	$2,021,760

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Lim	Chairman, Chief Executive Officer, and Co-Founder	$593,100	—	—	$6,583,018	$338,067	$9,150	$7,523,335
David Chacko	Chief Financial Officer and Chief Business Officer	$440,300	—	—	$3,047,039	$167,314	$9,150	$3,663,803
Wei Lin	M.D .^ Former Chief Medical Officer	$458,400	—	—	$2,264,525	$174,192	$9,150	$2,906,267

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wei Lin	M.D .^ Former Chief Medical Officer	$426,265	$200,000	—	$2,703,937	$221,450	$153,523	$3,705,175
Ebun S. Garner	—	$273,223	—	—	$2,471,630	$139,941	$6,836	$2,891,630
Jonathan Lim	Chairman and Chief Executive Officer	$497,846	—	—	—	$343,688	$8,700	$850,234

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Lim	Chairman and Chief Executive Officer	$300,000	—	—	$1,484,696	$180,000	—	$1,964,696

Executive changes

Person	Role	Change	Effective	Filed
Charles S. Fuchs, M.D., M.P.H.	President, Research & Development	Appointed	2026-08-10	2026-08-10
Shannon R. Morris, M.D., Ph.D.	Chief Medical Officer	Appointed	2023-04-10	2023-04-10
Wei Lin, M.D.	Chief Medical Officer	Resigned	2023-04-21	2023-04-10
Jean Liu, J.D.	Class III director	Appointed	2022-04-25	2022-04-27

Key facts CIK 1761918 CUSIP 29479A108 13F (30d) 248 filings 247 filers Visit website Investor relations